Combating Disease Through Innovative Therapies
Product PipelineExpanding the Potential of CAR T Cell Therapy
Our XCART platform is a novel CAR T technology engineered to target patient- and tumor-specific neoantigens.
XCART PlatformTransformative Technologies
Our proprietary and patented technologies are being utilized to create life-changing therapies.
Our Novel TechnologiesLatest News
Oct 08, 2019
Xenetic Biosciences, Inc. Provides Business OutlookStock Information
Nasdaq: XBIO
Xenetic Biosciences, Inc.
Price
Change
Volume
Day Range
52 Week Range
